← Back to the biomarker database

Organophosphate: the pathway in the body · Biomarker & Laboratory Analysis

This page shows the biochemical pathway of the substance Organophosphate: how it enters the body, which stations it passes and which steps it affects. Every statement has a source. The page describes general textbook knowledge and says nothing about any individual person.

In brief

Organophosphates are esters of phosphoric acid and are used as insecticides. In the liver they are converted into the oxon form, which binds to the active site of acetylcholinesterase. The enzyme can then no longer cleave acetylcholine, and the signal persists.

9 stations · 6 sources
ORYUptake and breakdownSite of action at the synapsePON1calciumacetylcholinesteraseCYP enzymesNADPHoxygenwith the blood to the synapseOrganophosphateester of phosphoric acidUptakevia skin, lungs and gutConversion in the livercytochrome P450Oxon formthe reactive formCleavage by PON1in blood, bound to HDLDialkyl phosphatesexcreted with the urineOxon at the enzymebinding to serineAcetylcholinemessenger at the synapseCholine + acetatecleavage products

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

  1. Organophosphate → Uptake Organophosphates enter the body via the skin, the airways and the gut. They dissolve in fat and pass through cell membranes. They thus reach the blood quickly. Source 1↑ supplies Because organophosphates dissolve in fat, skin, airways and gut bring them quickly into the blood and on into the tissues. established physiology Source 1
    ⚖ When the balance tips

    too much — If a lot is absorbed, more of it also spreads into adipose tissue, from which it is slowly released again.

    too little — If little is absorbed, little reaches the liver, and the amounts in the blood stay small.

    observed in studies · Source 1

  2. Uptake → Conversion in the liver Enzymes of the cytochrome P450 family exchange the sulfur atom in the molecule for oxygen. CYP1A2, CYP2B6 and CYP3A4 are mainly involved. This forms the reactive oxon. Source 2, 4↑ supplies The CYP enzymes form the oxon from the thio compound, which binds to esterases; depending on the substance, the same enzymes also split part of it directly into inactive fragments. established physiology Source 2, 4
    ⚖ When the balance tips

    too much — If the CYP enzymes work quickly, a lot of oxon forms in a short time, and more of it reaches the blood.

    too little — If they work slowly, for example owing to differences in the CYP forms involved, less oxon forms, and more of the starting material remains.

    observed in studies · Source 2, 4

  3. Conversion in the liver → Oxon form CYP enzymes · NADPH, oxygen This yields the oxon form. It binds to the active site of esterases far more strongly than the parent compound does. It mainly occupies acetylcholinesterase. Source 2, 1↓ depletes The oxon form occupies the active site of esterases, above all acetylcholinesterase, and switches them off; carboxylesterases bind part of it before it reaches the nerves. established physiology Source 2, 1
    ⚖ When the balance tips

    too much — If more oxon forms than PON1 and carboxylesterases can capture, a larger part of the acetylcholinesterase is occupied.

    too little — If little oxon forms, PON1 and the carboxylesterases largely capture it before it reaches acetylcholinesterase.

    established physiology · Source 1, 3

  4. Oxon form → Cleavage by PON1 Paraoxonase 1 (PON1) is bound to HDL particles in the blood and cleaves the oxon form. Two calcium ions sit in its active site. Carboxylesterases also bind the oxon form. How fast depends partly on the form of the PON1 gene. Source 4, 5, 1↓ depletes PON1 cleaves the oxon form in the blood before it reaches acetylcholinesterase; how fast depends on the substance and on the form of the PON1 gene. established physiology Source 4, 5, 1
    ⚖ When the balance tips

    too much — If PON1 activity is high, more oxon is cleaved in the blood; in animal models acetylcholinesterase then remains less occupied.

    too little — If PON1 activity is low, for example owing to certain gene forms, the oxon stays in the blood longer; in animal models more acetylcholinesterase is then occupied.

    observed in studies · Source 4

  5. Cleavage by PON1 → Dialkyl phosphates PON1 · calcium Cleavage yields dialkyl phosphates such as dimethyl and diethyl phosphate. They are water-soluble and leave the body with the urine. They no longer act on esterases. Source 6↓ depletes Dialkyl phosphates are the fragments with which the phosphate part leaves the body via the urine; they no longer act on esterases. established physiology Source 6
    ⚖ When the balance tips

    too much — If a lot of organophosphate is cleaved, dialkyl phosphates in the urine rise within hours to days.

    too little — If little is cleaved, only a few dialkyl phosphates appear in the urine; part of them may also come from residues in food that have already broken down.

    established physiology · Source 6

  6. Acetylcholine → Choline + acetate acetylcholinesterase Acetylcholinesterase cleaves acetylcholine into choline and acetate. Choline is carried back into the nerve cell and joined into acetylcholine again there. This ends the signal. Source 3↑ supplies Cleavage ends the signal and returns choline, from which the nerve cell makes new acetylcholine. established physiology Source 3
    ⚖ When the balance tips

    too much — If a lot of choline forms because acetylcholine is cleaved rapidly, the nerve cell recovers it and makes new acetylcholine from it.

    too little — If little choline forms because acetylcholinesterase is occupied, the signal does not end, and the nerve cell gets less choline back.

    established physiology · Source 3

Further stations

Cofactors in this pathway

Sources

  1. Costa LG. Current issues in organophosphate toxicology. Clin Chim Acta 2006 · PubMed 16337171
  2. Buratti FM, Volpe MT et al. CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. Toxicol Appl Pharmacol 2003 · PubMed 12620367
  3. Colović MB, Krstić DZ et al. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 2013 · PubMed 24179466
  4. Furlong CE. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. J Biochem Mol Toxicol 2007 · PubMed 17936934
  5. Harel M, Aharoni A et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004 · PubMed 15098021
  6. Neves AP, Rosa ACS et al. Urinary dialkylphosphate metabolites in the assessment of exposure to organophosphate pesticides: from 2000 to 2022. Environ Monit Assess 2023 · PubMed 38049584

Related pathways

As of 2026-09-18. Draft, written by Claude to schema v2; sources checked in PubMed; expert approval pending
Legal notice Privacy policy All biomarkers